TRPML2 expression was also detected in normal astrocytes and neural stem/progenitor cells and to be up-regulated at both mRNA and protein level in glioma to a variable extent, increasing with the pathological grade (Morelli et al., 2016). The gene discussed is MCOLN2; the disease is glioma.